Abstract
The aim of this review is to present some of the recent publications on cannabidiol (CBD; 2), a major non-psychoactive constituent of Cannabis, and to give a general overview. Special emphasis is laid on biochemical and pharmacological advances, and on novel mechanisms recently put forward, to shed light on some of the pharmacological effects that can possibly be rationalized through these mechanisms. The plethora of positive pharmacological effects observed with CBD make this compound a highly attractive therapeutic entity.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Antioxidants / chemical synthesis
-
Antioxidants / therapeutic use
-
Brain Ischemia / drug therapy
-
Cannabidiol / agonists
-
Cannabidiol / chemical synthesis
-
Cannabidiol / therapeutic use*
-
Cannabinoid Receptor Antagonists*
-
Humans
-
Neoplasms / drug therapy
-
Neuroprotective Agents / chemical synthesis
-
Neuroprotective Agents / therapeutic use
-
Receptor, Serotonin, 5-HT1A / drug effects
-
Receptors, Opioid / drug effects
Substances
-
Antioxidants
-
Cannabinoid Receptor Antagonists
-
Neuroprotective Agents
-
Receptors, Opioid
-
Receptor, Serotonin, 5-HT1A
-
Cannabidiol